Valuation: AstraZeneca PLC

Market Cap 267B 234B 216B 199B 378B 25,477B 384B 2,578B 1,011B 12,549B 1,003B 981B 43,188B P/E 2026 *
21.6x
P/E 2027 * 19x
Enterprise Value 286B 251B 231B 214B 405B 27,320B 412B 2,764B 1,084B 13,457B 1,075B 1,052B 46,312B EV / Sales 2026 *
4.53x
EV / Sales 2027 * 4.18x
Free-Float
96.63%
Yield 2026 *
1.94%
Yield 2027 * 2.05%

Last Transcript: AstraZeneca PLC

1 day-3.89%
1 week-11.22%
Current month-8.98%
1 month-4.68%
3 months-15.73%
6 months-9.72%
Current year-6.93%
1 week 12,388
Extreme 12388
14,526
1 month 11,484
Extreme 11484
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jul. 05Free

See Remarks

2 0.0000%
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%-11.22%+20.78%+26.07% 267B
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
+0.66%-1.42%-29.26%-39.30% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
-0.33%-0.62%-5.77%-32.90% 138B
Average -1.09%-2.50%+23.00%+47.46% 371.17B
Weighted average by Cap. -1.28%-2.47%+34.87%+79.39%

Financials

2026 *2027 *
Net sales 63.2B 55.37B 51.06B 47.18B 89.45B 6,028B 90.94B 610B 239B 2,969B 237B 232B 10,218B 66.77B 58.5B 53.94B 49.84B 94.5B 6,368B 96.08B 644B 253B 3,137B 251B 245B 10,795B
Net income 12.43B 10.89B 10.04B 9.28B 17.6B 1,186B 17.89B 120B 47.06B 584B 46.67B 45.66B 2,010B 13.94B 12.21B 11.26B 10.4B 19.72B 1,329B 20.05B 134B 52.75B 655B 52.32B 51.19B 2,253B
Net Debt 19.32B 16.93B 15.61B 14.42B 27.35B 1,843B 27.8B 186B 73.14B 908B 72.55B 70.97B 3,124B 11.85B 10.38B 9.57B 8.84B 16.77B 1,130B 17.04B 114B 44.84B 556B 44.47B 43.51B 1,915B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-10 GBX 12,834.00 -3.89% 3,355,019
26-07-09 GBX 13,354.00 -6.22% 7,624,478
26-07-08 GBX 14,240.00 -0.86% 1,480,149
26-07-07 GBX 14,364.00 +1.87% 1,528,247
26-07-06 GBX 14,100.00 -2.46% 2,008,204
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
172.23USD
Average target price
215.33USD
Spread / Average Target
+25.02%

Quarterly revenue - Rate of surprise